This ITRC guidance describes how to integrate bioavailability information into the human health risk assessment to improve the decision-making process.
Regulators, practitioners, and stakeholders will find help performing the following tasks:
- select and properly interpret site-specific bioavailability testing information
- understand the strengths and weaknesses of different in vivo and in vitro methods
- consider the factors for selecting the most appropriate approaches for a site-specific evaluation of bioavailability of contaminants in soil without compromising the level of protectiveness for human health
- use the appropriate tools to develop site-specific bioavailability values in human health risk assessment.
Publication Date: November 2017